JAK2 and lung adenocarcinoma: Our findings suggest that ubenimex alone or in combination with pemetrexed could inhibit the occurrence and development of malignant biological behavior of lung adenocarcinoma cells by upregulating SOCS1 expression and then inhibiting the JAK2-STAT3 signaling pathway.